We are live on ! Find out more
IVF

INVO Fertility Inc

7 hedge funds and large institutions have $194K invested in INVO Fertility Inc in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

89% more capital invested

Capital invested by funds: $103K → $194K (+$91.8K)

40% more funds holding

Funds holding: 57 (+2)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

IVF Hedge Fund Activity: Q3 2024 in Review

7 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q3 2024, worth a combined $194K — up 89% from $103K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new IVF positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $42.3K. The largest seller was Virtu Financial, exiting entirely with an estimated $11K sold.

  • 7 institutional investors held INVO Fertility Inc (IVF) as of Q3 2024, up from 5 in Q2 2024.
  • Funds reported $194K of INVO Fertility Inc stock for Q3 2024, up 89% quarter-over-quarter.
  • 3 funds opened new INVO Fertility Inc positions in Q3 2024 and 1 closed out, a net change of +2 holders.
  • The largest INVO Fertility Inc buyer in Q3 2024 was Citadel Advisors, an estimated $42.3K added.
  • The largest INVO Fertility Inc seller in Q3 2024 was Virtu Financial, an estimated $11K sold.

Based on aggregated 13F filings for Q3 2024.